UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 21, 2025

Accession Number:	0001193125-25-059363
Submission Type:	POS AM
CIK: 0001730463 Company Name: Autolus Therapeutics plc File Number: 333-276942